Shaolin Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Shaolin Capital Management’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	0	–	–	–	554
2023 Q2	–	Sell	-1,667	Closed	-$2.07M	–	645
2023 Q1	$2.05M	Hold	1,667	–	–	0.06%	236
2022 Q4	$2.03M	Hold	1,667	–	–	0.06%	294
2022 Q3	$1.97M	Sell	1,667 -10,000	-86%	-$12M	0.05%	358
2022 Q2	$13.9M	Buy	11,667 +1,911	+20%	+$2.28M	0.34%	53
2022 Q1	$11.6M	Buy	9,756 +8,298	+569%	+$9.8M	0.29%	69
2021 Q4	$1.72M	Buy	+1,458	New	+$1.72M	0.04%	411

Other funds holding CLDI

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return

Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return